podophyllotoxin has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dhurandhar, NV; Feizy, Z; Hegde, V; Peddibhotla, S; Shastri, AA | 1 |
| Chen, S; Jing, X; Ling, H; Liu, H; Liu, Y; Qin, Y; Sun, B; Sun, T; Sun, Y; Xiao, T; Yang, C; Zhang, X; Zhong, W; Zhou, H; Zhou, L | 1 |
2 other study(ies) available for podophyllotoxin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
E4orf1: A protein for enhancing glucose uptake despite impaired proximal insulin signaling.
Topics: 3T3-L1 Cells; Adenoviruses, Human; Animals; Diabetes Mellitus, Type 2; Glucose; Glucose Transporter Type 4; Insulin; Mice; Models, Biological; Peptides; Phosphorylation; Podophyllotoxin; Proto-Oncogene Proteins c-akt; Signal Transduction; Viral Proteins; Wortmannin | 2018 |
Novel Podophyllotoxin Derivatives as Partial PPARĪ³ Agonists and their Effects on Insulin Resistance and Type 2 Diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dogs; Drug Evaluation, Preclinical; Glucose; HEK293 Cells; Hep G2 Cells; Humans; Hypoglycemic Agents; Insulin Resistance; Islets of Langerhans; Madin Darby Canine Kidney Cells; Mice; Molecular Docking Simulation; NIH 3T3 Cells; Podophyllotoxin; PPAR gamma; Rats, Wistar | 2016 |